½üÈÕ£¬É½¶«´óѧÆë³ҽԺÆÕÍâ¿ÆF5C²¡·¿³É¹¦ÊµÊ©ÎÒÔºÊ×Àý¸¹Ç»¾µ¸¨ÖúÁªºÏ¸ÎÔàÀë¶ÏºÍÞ²Âö½áÔúµÄ¶þ²½¸ÎÇгýÊõ(associating liver partition and portal vein ligation for staged hepatectomy, ALPPS)¡£
»¼ÕßÄÐÐÔ£¬36Ë꣬ÒòÓÒÉϸ¹ÌÛÍ´10ÓàÌìÈëסɽ¶«´óѧÆë³ҽԺ¡£
¸¹²¿Ç¿»¯CTʾ£º¸ÎÄڶ෢ռλÐÔ²¡±ä£¬¿¼ÂǾ޿éÐ͸ΰ©²¢¸ÎÄڶ෢תÒÆ£¬ÔÚµ±µØÒ½ÔºÄâÐнéÈëÖÎÁÆ£¬ºó»¼ÕßÀ´É½¶«´óѧÆë³ҽԺ¾ÍÕCTÏÔʾÖ×ÁöΪ¶à·¢£¬µ«ÊǾÖÏÞÓÚÓÒ°ë¸Î£¬¿É¿¼ÂÇÐÐÓÒ°ë¸ÎÇгýÊõ£¬µ«ÊÇ»¼Õß×ó°ë¸ÎÌå»ýСÓÚ40%£¬²¢ÇÒ°éÓиÎÓ²»¯£¬ÓÒ°ë¸ÎÊÖÊõºó¸ÎË¥½ßµÈ²¢·¢Ö¢·¢ÉúÂʸߡ£
½áºÏ»¼Õß²¡Ç飬ÆÕÍâ¿ÆF5C²¡·¿¾¹ý¿ÆÊÒÌÖÂÛ£¬¾ö¶¨Ðи¹Ç»¾µ¸¨ÖúALPPSÊÖÊõ¡£
ÊÖÊõ·ÖΪÁ½²½£¬Ê×ÏÈÔÚ¸¹Ç»¾µÏÂÐÐÞ²ÂöÓÒÖ§½áÔú£¬Ê¹Ê£Óà¸ÎÔàÌå»ýÔö´ó£¬È»ºóÐÐÓÒ°ë¸ÎÇгý¡£ÊÖÊõÓɺúÈýÔª½ÌÊÚ¡¢½ù±ó¸±½ÌÊÚ¡¢¶Å¸ÕÖ÷ÖÎҽʦ¡¢ÕÅÊ¿ÕÜҽʦ¡¢Àî¼Ñҽʦʵʩ¡£µÚÒ»ÆÚÊÖÊõÇé¿ö£º¸¹±Ú¡¢Åèǻδ¼ûתÒƽá½Ú£¬¸ÎÔà³Ê½á½ÚÐÔ¸ÎÓ²»¯±íÏÖ£¬Ö×ÁöλÓÚÓÒ°ë¸Î£¬Ê£Óà¸ÎÔàÌå»ý½ÏС£¬Ê×ÏÈÇгýµ¨ÄÒ£¬È»ºó½âÆʵÚÒ»¸ÎÃÅ£¬ÏԶÞ²ÂöÓÒÖ§£¬ÒÔ7ºÅÏß½«Æä½áÔú£¬²¢ÒÔhem-o-lock¼Ð¼Ð±Õ£¬´Ëʱ¿É¼ûÓÒ°ë¸ÎÑÕÉ«±ä°µ£¬½áÊøÊÖÊõ¡£
Êõºó»¼Õß°²·µ²¡·¿£¬ÊõºóµÚ1Ìì½øÒûʳ£¬²¢Ï´²»î¶¯£¬Êõºó¸øÓ迹Ñס¢±£¸ÎµÈÏàÓ¦ÖÎÁÆ£¬Êõºó12Ì츴²é¸¹²¿Ç¿»¯CT£¬ÏÔʾ×ó¸ÎÌå»ýÔö´ó£¬ÆÀ¹À¸ÎÔàÌå»ýÔ¼632cm ³£¬Äܹ»ÄÍÊÜÊÖÊõ£¬ÓÚÊõºóµÚ15ÌìÐÐÓÒ°ë¸ÎÇгýÊõ¡£
µÚ¶þÆÚÊÖÊõÇé¿ö£ºÓÒ°ë¸Î¿É¼û¶à´¦Ö×Áö£¬´óÕßÔ¼10¡Á10cm£¬¸ÎÊ®¶þÖ¸³¦ÈÍ´øË®Ö×£¬Ê×ÏȽâÆʵÚÒ»¸ÎÃÅ£¬½âÆʳöÓҸζ¯Âö£¬½«Æä½áÔúÇжϣ¬ÏÔ¶µÚÈý¸ÎÃÅ£¬½áÔúÇжϸζÌѪ¹Ü£¬»¼Õ߸ÎÓÒºóÏÂѪ¹ÜÖ±¾¶Ô¼1cm£¬ÒÔENDO-Cut½«Æä±ÕºÏÀë¶Ï£¬ÏÔ¶µÚ¶þ¸ÎÃÅ£¬ÒÔENDO-Cut±ÕºÏÀë¶Ï¸ÎÓÒ¾²Âö£¬¾àÖ×Áö±ßÔµ2cm»®³öÔ¤ÇÐÏߣ¬½«ÓÒ°ë¸ÎÇгý£¬½áÊøÊÖÊõ£¬ÊÖÊõ˳Àû£¬Êõºó»¼Õß°²·µ²¡·¿¡£
Êõºó²¡Àíʾ£º(¸Î)¸Îϸ°û¸Î°©£¬ÇÐԵδ²é¼û°©¡£»¼ÕßÊõºóÔçÆÚ½øÒûʳ£¬²¢Ï´²»î¶¯£¬Ä¿Ç°»Ö¸´Á¼ºÃ£¬Ë³Àû³öÔº¡£
¶ÔÓÚ¸ÎÔàµÄÔ·¢»ò¼Ì·¢Ö×Áö£¬¸ùÖÎÐÔ¸ÎÇгýÊõÊÇ»ñµÃ³¤ÆÚÔ¤ºóµÄ×î¼ÑÑ¡Ôñ¡£µ«ÊÇ£¬Ê£Óà¸ÎÔàÌå»ý(future liver remnant,FLR)²»×ãÊÇÊõºó»¼ÕßËÀÍöÂʼ°²¢·¢Ö¢·¢ÉúÂʵÄÖ÷ÒªÓ°ÏìÒòËØ£¬Ò²ÊÇÄ¿Ç°À©´ó¸ÎÇгý·¢Õ¹µÄÀ§ÈÅ¡£
1980ÄêMakuuchiÊ×ÏÈÌá³öÁËÞ²ÂöÓÒ֧˨Èû¼¼Êõ(portal vein embolisation£¬PVE)£¬´Ó¶øʹ×ó¸ÎÌå»ýÔö´ó£¬°²È«¿ªÕ¹ÁËÓÒ°ë¸ÎÊÖÊõ£¬2011Äê¹ú¼ÊÉÏÕýʽ±¨µÀÁËÁªºÏ¸ÎÔàÀë¶ÏºÍÞ²Âö½áÔúµÄ¶þ²½¸ÎÇгýÊõ(ALPPS)£¬ÄÜÔÚ¶Ìʱ¼äÄÚʹʣÓà¸ÎÔàÌå»ýÔö¼Ó£¬Ê¹»¼ÕßÄܹ»µÃµ½¸ùÖÎÐÔÊÖÊõµÄ»ú»á¡£½üÄêÀ´£¬ALPPSÊÖÊõÔÚ¹ú¼ÊÉϵõ½Öð½¥Íƹ㣬ĿǰȫÇòÒÑÓг¬¹ý300ÀýµÄ²¡Àý±¨µÀ£¬¹úÄÚ¿ªÕ¹µÄALPPSÊÖÊõÔ¼50ÓàÀý¡£
ALPPSÊÇÒ»ÖÖеÄÊÖÊõ·½Ê½£¬¶ÔÓÚÎÞ·¨ÇгýµÄ¸ÎÔàÖ×ÁöÖÎÁÆ·½°¸µÄÑ¡ÔñÌá³öÁËеÄ˼·£¬ÎªÎÞ·¨ÇгýµÄ¸ÎÔàÖ×Áö»¼ÕßÌṩÁËеÄÏ£Íû£¬Ïà±È½ÏÆäËûµÄһЩÖÎÁÆ·½°¸£¬ÄÜÃ÷ÏÔÑÓ³¤»¼ÕßµÄÉú´æʱ¼ä¡£Ëæ×ÅALPPSµÄÖð½¥Íƹ㣬ALPPS½«ÔÚ¸ÎÔàÖ×ÁöµÄÖÎÁÆÖз¢»ÓÔ½À´Ô½ÖØÒªµÄ×÷Óá£
ALPPSµÄÊÊÓ¦Ö¤£ºÊ£Óà¸ÎÔ಻×ãµÄ¸ÎÔàÔ·¢»ò¼Ì·¢¶ñÐÔÖ×Áö»¼Õߣ¬ÊõÇ°Ó°ÏñѧÆÀ¹ÀÕý³£¸ÎÔàFLR<40%¡£Ä¿Ç°´ó²¿·Ö( 50%-70%) ALPPS ÊÖÊõÊÇÔڽ᳦°©Êõºó¸ÎתÒÆ»¼ÕßÖÐʵʩ£¬ÔÚÔ·¢ÐԸΰ©£¬ÌرðÊÇÔںϲ¢¸ÎÓ²»¯µÄ»¼ÕßÖÐʵʩ½ÏΪÉÙ¼û¡£
½áºÏPVE¼°ALPPS£¬É½¶«´óѧÆë³ҽԺ³É¹¦¿ªÕ¹Ò½ÔºÊ×Àý¸¹Ç»¾µ¸¨ÖúALPPSÊÖÊõ¡£´ËÀýÊÖÊõÌص㣺µÚÒ»ÆÚÊÖÊõÍêÈ«ÔÚ¸¹Ç»¾µÏÂÍê³É£¬¼õÉÙÁËÊÖÊõµÄÕ³Á¬£¬ÎªµÚ¶þÆÚÊÖÊõÌṩÁËÌõ¼þ£¬²¢ÇÒ»¼ÕßµÚÒ»ÆÚÊÖÊõ´´ÉËС£¬»Ö¸´¿ì£¬Í´¿àС;Ïà±È½Ï´«Í³µÄPVE£¬¼ÈÄÜÓÐЧµÄ×è¶ÏÓҸεÄÖ÷ҪѪÁ÷£¬ÓÖÄܼõÉÙÁ½´ÎÊÖÊõµÄ¼ä¸ôʱ¼ä(´«Í³PVE¼ä¸ôÒ»°ã´óÓÚ4ÖÜ);¼õÉÙÁ˵¨Â©¡¢¸ÐȾµÈ²¢·¢Ö¢µÄ·¢Éú¼¸ÂÊ¡£